Triamcinolone acetonide, sold under the brand name Kenalog among others, is a synthetic corticosteroid medication used topically to treat various skin conditions, to relieve the discomfort of mouth sores, and by injection into joints to treat various join. Chemically it is the acetonide ester of triamcinolone (C24H31FO6, molar mass about 434.5 g/mol) and functions as a potent glucocorticoid receptor agonist with anti inflammatory, immunosuppressive, antipruritic, and vasoconstrictive effects. Formulations include creams, ointments, sprays, dental pastes, and injectable suspensions for intra articular or soft tissue use. In topical and intralesional applications the acetonide modification increases local potency and duration while limiting systemic exposure when used as directed. Quality control for active pharmaceutical ingredient and finished product addresses particle size, dissolution or release characteristics for topical bases, residual solvents, microbial limits for non sterile formulations, and validated analytical methods such as HPLC for assay and related substance profiling.
Parent: Triamcinolone
Parent: Triamcinolone
Parent: Triamcinolone
Parent: Triamcinolone
Parent: Triamcinolone
Parent: Triamcinolone
Parent: Triamcinolone Acetonide
Parent: Triamcinolone
Parent: Triamcinolone/ Triamcinolone Hexacetonide
Parent: Triamcinolone
Typical impurity and related compound control for triamcinolone acetonide includes identification and quantitation of known related substances such as parent triamcinolone, 21 deacylated or 21 acetylated derivatives, 16,17 acetonide epimers, and other oxidation or dehydro degradation products. Typical manufacturer and compendial acceptance criteria used in quality control are: assay within an expected range near label claim (commonly around 98.0 to 102.0 percent of declared potency for the API), individual specified related compounds commonly limited in the range of 0.1 to 0.5 percent depending on the impurity, and total impurities generally limited to about 1.0 percent or less. Exact limits and identification requirements vary by pharmacopeial monograph and regulatory filing and are established by validated stability and forced degradation studies specific to each formulation.
Triamcinolone acetonide is used to reduce inflammation and itching in dermatologic conditions, to relieve pain and inflammation from intra articular or soft tissue injections, and as a topical dental paste to ease discomfort from mouth sores and mucosal lesions.
Triamcinolone topical preparations can be used to reduce inflammation and itching from poison ivy when applied as directed, typically for short courses; severe or widespread exposure, signs of infection, or involvement of the face or genitals should prompt evaluation by a healthcare professional before steroid use.
Triamcinolone is a corticosteroid, not an antifungal. It treats inflammation and immune mediated skin problems but does not treat fungal infections and can worsen an untreated fungal infection if used alone.
Onset of symptom relief can begin within hours for injectable forms and within a day for many topical applications, with maximal improvement often observed after several days of appropriate use; response time depends on formulation potency, lesion severity, site of application, and whether the product is used under occlusion.
